As of 2025-07-13, the Intrinsic Value of Andromeda Metals Ltd (ADN.AX) is 0.04 AUD. This ADN.AX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 0.01 AUD, the upside of Andromeda Metals Ltd is 244.80%.
The range of the Intrinsic Value is 0.03 - 0.05 AUD
Based on its market price of 0.01 AUD and our intrinsic valuation, Andromeda Metals Ltd (ADN.AX) is undervalued by 244.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (0.13) - (0.03) | (0.05) | -531.1% |
| DCF (Growth 10y) | (0.03) - (0.09) | (0.04) | -412.3% |
| DCF (EBITDA 5y) | 0.03 - 0.05 | 0.04 | 244.8% |
| DCF (EBITDA 10y) | 0.03 - 0.05 | 0.04 | 195.0% |
| Fair Value | -0.01 - -0.01 | -0.01 | -158.93% |
| P/E | (0.02) - (0.03) | (0.02) | -283.3% |
| EV/EBITDA | (0.02) - 0.01 | (0.01) | -156.5% |
| EPV | (0.04) - (0.05) | (0.04) | -467.0% |
| DDM - Stable | (0.01) - (0.09) | (0.05) | -520.3% |
| DDM - Multi | (0.01) - (0.04) | (0.01) | -222.0% |
| Market Cap (mil) | 45.76 |
| Beta | 3.39 |
| Outstanding shares (mil) | 3,813.34 |
| Enterprise Value (mil) | 43.03 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.05% |
| Cost of Debt | 5.00% |
| WACC | 7.99% |